Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial Meeting Abstract
| Authors: | Topalian, S. L.; Sznol, M.; Brahmer, J. R.; McDermott, D. F.; Smith, D. C.; Gettinger, S. N.; Taube, J. M.; Drake, C. G.; Pardoll, D. M.; Powderly, J. D.; Carvajal, R. D.; Sosman, J. A.; Atkins, M. B.; Antonia, S. J.; Spigel, D. R.; Lawrence, D. P.; Kollia, G.; Gupta, A. K.; Wigginton, J. M.; Hodi, F. S. |
| Abstract Title: | Nivolumab (anti-PD-1; BMS-936558; ONO-4538) in patients with advanced solid tumors: Survival and long-term safety in a phase I trial |
| Meeting Title: | 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 31 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2013 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2013-05-20 |
| Language: | English |
| ACCESSION: | WOS:000335419601135 |
| PROVIDER: | wos |
| DOI: | 10.1200/jco.2013.31.15_suppl.3002 |
| Notes: | Meeting Abstract: 3002^ -- Source: Wos |
